Eric Brandt

Director Eric Brandt sells 54,500 shares at avg $367.18 for $20.0M under pre-arranged 10b5-1 plan

Eric Brandt, a Director of Lam Research, executed 17 separate sales totaling 54,500 shares for $20,011,345.71 on 2026-06-12, reducing his holdings by 27.4% from 199,205 to 144,705 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-02-06, meaning the sales were scheduled and not discretionary decisions made in response to current market conditions. The blended average sale price of $367.18 compares to the current price of $389.60, and notably the stock has risen 36.8% in the 30 days and 72.0% in the 90 days following the transaction date. Brandt's prior two sales at LRCX on 2026-02-06 showed 30-day returns of -9.8% and -13.3% respectively, while the subsequent 90-day returns were positive at +29.7% and +24.6%, reflecting a pattern where the stock recovered and climbed after his scheduled sales.

Director Eric Brandt sold 54,500 shares of LRCX for $19.1M on 2026-06-11 under 10b5-1 plan; post-sale holdings 199.2K shares

Eric Brandt executed 26 separate sales totaling 54,500 shares for $19,118,359.86 on 2026-06-11 at prices ranging from $337.56 to $364.00, reducing his holdings by -21.5% to 199,205 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-02-06, meaning the sales were scheduled and not discretionary. Stock price has subsequently risen 36.8% over the past 30 days and 72.0% over 90 days from the transaction date, with current price at $389.60. His prior two sales at this same ticker also occurred on 2026-02-06, showing a pattern of scheduled dispositions on this stock."

Director Eric Brandt sells 35,000 LRCX shares for $7,896,150.00 across 2 transactions on 2026-02-06

BRANDT ERIC (Director) executed two separate sales totaling 35,000 shares on 2026-02-06, selling 17,000 shares at $220.95 and 18,000 shares at $230.00 for a combined $7,896,150.00. The sales reduced his holdings by 12.1%, from 288.7K shares to 253.7K shares, while the stock's 52-week range of $59.09–$248.17 places the transaction prices near the upper end of recent trading. With LAM RESEARCH posting $5.3B in quarterly revenue, +23.7% annual growth, and a P/E of 46.04, the company remains valued at $286.3B. The director's reduction of a substantial position warrants monitoring of any future filing patterns at the company.